These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 16326226

  • 1. Hyperlipidemia.
    Eaton CB.
    Prim Care; 2005 Dec; 32(4):1027-55, viii. PubMed ID: 16326226
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The lipid management nutrition outcomes project: perspectives from a national experience in protocol implementation and nutrition outcomes tracking.
    Rhodes KS, Weintraub MS, Biesemeier CK, Rubenfire M.
    J Am Diet Assoc; 2008 Feb; 108(2):332-9. PubMed ID: 18237579
    [Abstract] [Full Text] [Related]

  • 4. Practical management of lipid disorders.
    Skillings J.
    Lippincotts Prim Care Pract; 1998 Feb; 2(5):472-84. PubMed ID: 9791385
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Management of hyperlipidemias: an update.
    Ranjan N.
    Indian J Dermatol Venereol Leprol; 2009 Feb; 75(5):452-62. PubMed ID: 19736423
    [Abstract] [Full Text] [Related]

  • 9. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L, Reyes R, Johnson-Levonas AO, Sapre A, Tribble DL, Musliner T.
    Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Influence of combined, hypolipemic therapy on lipids and non-lipid atherosclerosis risk factors].
    Broncel M, Balcerak M, Chojnowska-Jezierska J.
    Pol Merkur Lekarski; 2007 Jan; 22(127):62-5. PubMed ID: 17477094
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lipid management in patients with vascular disease.
    Kohlman-Trigoboff D.
    J Vasc Nurs; 2005 Jun; 23(2):72-6. PubMed ID: 16102476
    [Abstract] [Full Text] [Related]

  • 15. Hypercholesterolemia treatment patterns and low-density lipoprotein cholesterol monitoring in patients with a diagnosis of atherosclerosis in clinical practice.
    Davidson MH, Gandhi SK, Ohsfeldt RL, Fox KM.
    Am J Med; 2009 Jan; 122(1 Suppl):S51-9. PubMed ID: 19110088
    [Abstract] [Full Text] [Related]

  • 16. [Importance of the clofibrat in the treatment of lipid metabolism disorders].
    Laubinger G.
    Med Klin; 1968 Jan 26; 63(4):139-42. PubMed ID: 5670163
    [No Abstract] [Full Text] [Related]

  • 17. Ezetimibe/simvastatin (INEGY) in the treatment of hyperlipidaemia.
    Kastelein JJ, Sankatsing RR.
    Int J Clin Pract; 2005 Dec 26; 59(12):1464-71. PubMed ID: 16351680
    [Abstract] [Full Text] [Related]

  • 18. Hyperlipidemia in adolescents.
    Kanani PM, Sperling MA.
    Adolesc Med; 2002 Feb 26; 13(1):37-52, v-vi. PubMed ID: 11841954
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
    Sorensen SV, Frick KD, Wade A, Simko R, Burge R.
    Clin Ther; 2009 Apr 26; 31(4):862-79. PubMed ID: 19446159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.